Nifty
Sensex
:
:
15699.25
52727.98
142.60 (0.92%)
462.26 (0.88%)

Pharmaceuticals & Drugs - Global

Rating :
61/99

BSE: 500420 | NSE: TORNTPHARM

2869.25
24-Jun-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 2877.75
  • 2911.00
  • 2857.75
  • 2855.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  72728
  •  2093.95
  •  3298.50
  •  2484.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 48,655.97
  • 62.67
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 52,926.60
  • 1.67%
  • 8.18

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 0.47%
  • 7.25%
  • FII
  • DII
  • Others
  • 10.88%
  • 9.69%
  • 0.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.50
  • 6.60
  • 1.42

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.29
  • 12.36
  • 4.53

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.99
  • 6.04
  • 42.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.98
  • 39.54
  • 41.02

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.77
  • 6.76
  • 7.59

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.25
  • 18.48
  • 19.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
2,131.00
1,937.00
10.02%
2,108.00
1,995.00
5.66%
2,137.00
2,017.00
5.95%
2,134.00
2,056.00
3.79%
Expenses
1,570.00
1,355.00
15.87%
1,570.00
1,388.00
13.11%
1,477.00
1,382.00
6.87%
1,457.00
1,395.00
4.44%
EBITDA
561.00
582.00
-3.61%
538.00
607.00
-11.37%
660.00
635.00
3.94%
677.00
661.00
2.42%
EBIDTM
26.33%
30.05%
25.52%
30.43%
30.88%
31.48%
31.72%
32.15%
Other Income
56.00
39.00
43.59%
48.00
8.00
500.00%
51.00
6.00
750.00%
40.00
4.00
900.00%
Interest
57.00
73.00
-21.92%
62.00
91.00
-31.87%
71.00
92.00
-22.83%
68.00
102.00
-33.33%
Depreciation
162.00
165.00
-1.82%
167.00
167.00
0.00%
168.00
165.00
1.82%
165.00
161.00
2.48%
PBT
-87.00
383.00
-
357.00
357.00
0.00%
472.00
384.00
22.92%
484.00
402.00
20.40%
Tax
31.00
59.00
-47.46%
108.00
60.00
80.00%
156.00
74.00
110.81%
154.00
81.00
90.12%
PAT
-118.00
324.00
-
249.00
297.00
-16.16%
316.00
310.00
1.94%
330.00
321.00
2.80%
PATM
-5.54%
16.73%
11.81%
14.89%
14.79%
15.37%
15.46%
15.61%
EPS
-6.97
19.14
-
14.71
17.55
-16.18%
18.67
18.32
1.91%
19.50
18.97
2.79%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
8,510.00
8,004.83
7,939.31
7,672.80
5,949.83
5,815.69
6,666.85
4,653.45
4,184.72
3,211.14
2,695.92
Net Sales Growth
6.31%
0.83%
3.47%
28.96%
2.31%
-12.77%
43.27%
11.20%
30.32%
19.11%
 
Cost Of Goods Sold
2,443.00
1,960.12
1,981.79
2,041.26
1,535.17
1,629.66
1,432.13
1,280.96
1,107.58
807.98
774.38
Gross Profit
6,067.00
6,044.71
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
1,921.54
GP Margin
71.29%
75.51%
75.04%
73.40%
74.20%
71.98%
78.52%
72.47%
73.53%
74.84%
71.28%
Total Expenditure
6,074.00
5,538.23
5,768.95
5,696.31
4,600.58
4,438.42
3,937.05
3,633.29
3,233.24
2,518.92
2,195.46
Power & Fuel Cost
-
122.94
128.19
132.46
118.77
107.98
92.59
97.41
71.88
62.80
56.97
% Of Sales
-
1.54%
1.61%
1.73%
2.00%
1.86%
1.39%
2.09%
1.72%
1.96%
2.11%
Employee Cost
-
1,439.62
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
741.10
623.29
531.80
% Of Sales
-
17.98%
18.00%
18.30%
19.08%
17.08%
12.63%
18.09%
17.71%
19.41%
19.73%
Manufacturing Exp.
-
550.92
544.11
558.84
457.58
502.16
353.45
345.98
320.78
278.15
225.27
% Of Sales
-
6.88%
6.85%
7.28%
7.69%
8.63%
5.30%
7.43%
7.67%
8.66%
8.36%
General & Admin Exp.
-
647.22
801.98
763.90
677.71
578.05
637.92
463.28
398.98
324.55
255.89
% Of Sales
-
8.09%
10.10%
9.96%
11.39%
9.94%
9.57%
9.96%
9.53%
10.11%
9.49%
Selling & Distn. Exp.
-
742.63
807.39
738.03
641.30
567.70
547.05
574.40
461.53
393.07
322.29
% Of Sales
-
9.28%
10.17%
9.62%
10.78%
9.76%
8.21%
12.34%
11.03%
12.24%
11.95%
Miscellaneous Exp.
-
74.78
76.45
58.03
34.80
59.46
31.56
29.45
131.39
29.08
322.29
% Of Sales
-
0.93%
0.96%
0.76%
0.58%
1.02%
0.47%
0.63%
3.14%
0.91%
1.07%
EBITDA
2,436.00
2,466.60
2,170.36
1,976.49
1,349.25
1,377.27
2,729.80
1,020.16
951.48
692.22
500.46
EBITDA Margin
28.63%
30.81%
27.34%
25.76%
22.68%
23.68%
40.95%
21.92%
22.74%
21.56%
18.56%
Other Income
195.00
75.73
121.30
63.62
298.84
223.30
228.80
285.55
38.13
43.36
44.70
Interest
258.00
358.28
450.71
503.75
308.48
205.56
183.98
175.16
58.63
33.80
39.45
Depreciation
662.00
657.79
654.38
617.69
408.60
306.92
237.55
190.74
87.00
82.69
81.73
PBT
1,226.00
1,526.26
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
843.98
619.09
423.98
Tax
449.00
274.38
161.85
125.35
252.87
154.51
610.17
188.84
180.07
146.69
72.32
Tax Rate
36.62%
17.98%
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
20.17%
PAT
777.00
1,251.88
1,024.72
436.28
678.11
933.55
1,733.24
750.94
663.88
432.76
284.04
PAT before Minority Interest
777.00
1,251.88
1,024.72
436.31
678.14
933.58
1,733.27
750.97
663.91
434.91
286.30
Minority Interest
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
-2.26
PAT Margin
9.13%
15.64%
12.91%
5.69%
11.40%
16.05%
26.00%
16.14%
15.86%
13.48%
10.54%
PAT Growth
-37.94%
22.17%
134.88%
-35.66%
-27.36%
-46.14%
130.81%
13.11%
53.41%
52.36%
 
EPS
45.92
73.99
60.56
25.78
40.08
55.17
102.44
44.38
39.24
25.58
16.79

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
5,837.17
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
1,193.83
Share Capital
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
42.31
42.31
Total Reserves
5,752.55
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
1,151.52
Non-Current Liabilities
2,924.20
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
487.73
Secured Loans
2,963.27
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
223.83
Unsecured Loans
0.00
1.56
3.11
6.15
11.26
10.62
13.62
13.74
51.35
98.22
Long Term Provisions
369.62
338.34
288.52
286.66
263.04
246.36
207.49
190.43
129.51
110.45
Current Liabilities
4,891.62
5,454.16
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
1,362.84
Trade Payables
2,066.81
2,048.81
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
863.47
Other Current Liabilities
1,635.36
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
371.63
275.83
291.00
Short Term Borrowings
704.40
1,090.85
934.11
1,625.60
0.00
3.32
319.07
210.43
124.62
138.12
Short Term Provisions
485.05
453.70
493.21
376.65
301.80
199.66
230.81
163.39
242.46
70.25
Total Liabilities
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
Net Block
7,064.63
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
796.87
Gross Block
10,511.53
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
1,199.64
Accumulated Depreciation
3,446.90
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
544.70
458.33
402.77
Non Current Assets
8,129.77
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
1,060.78
Capital Work in Progress
889.38
711.93
617.12
646.94
519.49
1,041.58
678.33
534.11
285.28
113.55
Non Current Investment
42.09
2.09
2.09
0.09
0.09
0.09
0.06
0.03
0.03
37.52
Long Term Loans & Adv.
81.56
222.19
150.58
130.96
182.32
99.66
206.92
129.47
62.84
61.37
Other Non Current Assets
52.11
126.28
196.03
72.22
122.40
85.25
50.28
60.74
23.90
46.25
Current Assets
5,523.22
4,980.92
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
1,987.12
Current Investments
139.05
0.02
351.35
492.27
803.55
779.59
297.59
185.63
60.44
86.52
Inventories
2,681.20
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
531.56
Sundry Debtors
1,523.37
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
522.80
Cash & Bank
603.50
666.65
816.04
867.23
893.72
647.03
567.36
769.42
626.97
674.28
Other Current Assets
576.10
443.21
405.83
587.77
672.16
459.34
532.03
343.95
261.80
171.96
Short Term Loans & Adv.
62.32
73.48
93.46
95.39
82.62
90.18
109.09
84.95
75.95
56.46
Net Current Assets
631.60
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
624.28
Total Assets
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
2,010.69
1,392.91
1,798.08
894.15
1,008.84
2,742.12
810.20
599.42
153.48
499.13
PBT
1,526.26
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
843.98
581.60
358.62
Adjustment
998.18
876.21
1,418.19
606.92
430.27
552.44
337.96
136.79
126.13
79.64
Changes in Working Capital
-338.25
-385.83
99.39
-360.16
-125.21
423.58
-409.38
-119.68
-421.75
143.58
Cash after chg. in Working capital
2,186.19
1,676.95
2,079.24
1,177.77
1,393.15
3,319.46
868.39
861.09
285.98
581.84
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-175.50
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
-82.71
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-449.42
198.61
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
-136.97
Net Fixed Assets
-198.83
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
-84.67
Net Investments
-179.03
351.33
138.83
310.79
-17.69
-484.32
-111.97
-131.60
287.55
-47.29
Others
-71.56
226.08
230.63
-772.52
-177.21
117.89
216.24
83.80
-73.97
-5.01
Cash from Financing Activity
-1,656.13
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
-192.74
Net Cash Inflow / Outflow
-94.86
42.48
242.35
-395.41
29.02
469.12
-139.85
330.01
-68.49
169.42
Opening Cash & Equivalents
661.82
588.76
702.04
1,067.57
1,049.86
612.38
955.05
687.41
760.80
604.79
Closing Cash & Equivalent
572.56
661.82
940.06
702.04
1,067.57
1,049.86
864.95
955.05
687.41
760.80

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
344.90
284.99
279.15
273.11
257.04
206.46
147.16
112.41
84.02
70.54
ROA
9.20%
7.50%
3.15%
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
10.26%
ROE
23.49%
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
25.84%
ROCE
17.63%
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
23.65%
Fixed Asset Turnover
1.43
1.48
1.50
1.57
1.35
1.82
1.88
3.11
2.60
2.50
Receivable days
38.92
37.65
33.78
35.74
74.66
82.76
105.19
77.81
68.65
58.33
Inventory Days
59.24
49.84
49.01
57.16
90.90
66.19
81.17
84.02
82.53
70.03
Payable days
383.19
133.47
139.05
150.99
171.27
204.35
176.11
158.58
143.69
136.22
Cash Conversion Cycle
-285.04
-45.98
-56.26
-58.09
-5.72
-55.41
10.25
3.25
7.50
-7.86
Total Debt/Equity
0.84
1.21
1.28
1.40
0.58
0.67
1.10
0.59
0.49
0.48
Interest Cover
5.26
3.63
2.11
4.02
6.29
13.74
6.37
15.40
18.21
10.09

News Update:


  • Torrent Pharma enters into agreement with Dr Reddy's Laboratories
    27th May 2022, 09:37 AM

    The complete integration and transition of the brands are expected to be completed by June 2022

    Read More
  • Torrent Pharmaceuticals reports consolidated net loss of Rs 118 crore in Q4
    26th May 2022, 12:05 PM

    Total consolidated income of the company increased by 10.68% at Rs 2187 crore for Q4FY22

    Read More
  • Torrent Pharma - Quarterly Results
    25th May 2022, 17:50 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.